Free Trial

Xylem (NYSE:XYL) Hits New 1-Year High - Should You Buy?

Xylem logo with Business Services background

Key Points

  • Xylem Inc.'s stock has reached a new 52-week high of $151.00 during trading, with the last transaction at $149.53 and a volume of over 41,000 shares.
  • Various analysts have upgraded their ratings on Xylem, with Wall Street Zen moving from "hold" to "buy," while Citigroup increased its price target to $152.00.
  • The company has announced a quarterly dividend of $0.40 per share, yielding 1.1%, and its current dividend payout ratio stands at 41.56%.
  • MarketBeat previews the top five stocks to own by November 1st.

Xylem Inc. (NYSE:XYL - Get Free Report)'s stock price hit a new 52-week high during mid-day trading on Monday . The company traded as high as $151.00 and last traded at $149.53, with a volume of 41065 shares changing hands. The stock had previously closed at $149.85.

Analyst Ratings Changes

A number of research firms have commented on XYL. TD Cowen upped their price target on Xylem from $125.00 to $130.00 and gave the company a "hold" rating in a research report on Tuesday, August 26th. Wall Street Zen upgraded Xylem from a "hold" rating to a "buy" rating in a report on Saturday, August 9th. Weiss Ratings reiterated a "buy (b)" rating on shares of Xylem in a report on Saturday, September 27th. Citigroup restated a "buy" rating and issued a $152.00 price objective (up from $137.00) on shares of Xylem in a report on Monday, July 14th. Finally, Zacks Research raised shares of Xylem from a "hold" rating to a "strong-buy" rating in a research note on Monday, September 22nd. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, Xylem has an average rating of "Moderate Buy" and an average price target of $152.33.

View Our Latest Report on Xylem

Xylem Trading Down 0.2%

The stock has a fifty day simple moving average of $141.96 and a 200 day simple moving average of $129.55. The firm has a market capitalization of $36.39 billion, a P/E ratio of 38.86, a PEG ratio of 2.59 and a beta of 1.13. The company has a quick ratio of 1.43, a current ratio of 1.90 and a debt-to-equity ratio of 0.17.

Xylem (NYSE:XYL - Get Free Report) last issued its earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.15 by $0.11. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The company had revenue of $2.30 billion for the quarter, compared to the consensus estimate of $2.20 billion. During the same quarter last year, the company earned $1.09 EPS. The firm's quarterly revenue was up 6.1% on a year-over-year basis. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. As a group, research analysts forecast that Xylem Inc. will post 4.65 EPS for the current year.

Xylem Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Thursday, August 28th were paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend was Thursday, August 28th. Xylem's dividend payout ratio (DPR) is presently 41.56%.

Insider Buying and Selling

In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $139.96, for a total transaction of $139,960.00. Following the completion of the transaction, the chief accounting officer owned 2,957 shares of the company's stock, valued at $413,861.72. This represents a 25.27% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.27% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Xylem

Hedge funds have recently bought and sold shares of the business. NBC Securities Inc. bought a new position in shares of Xylem during the 1st quarter valued at approximately $72,000. Merit Financial Group LLC grew its stake in Xylem by 13.0% in the 1st quarter. Merit Financial Group LLC now owns 2,707 shares of the industrial products company's stock worth $323,000 after acquiring an additional 312 shares in the last quarter. Procyon Advisors LLC raised its position in Xylem by 13.1% during the 1st quarter. Procyon Advisors LLC now owns 3,601 shares of the industrial products company's stock valued at $430,000 after purchasing an additional 416 shares in the last quarter. Perennial Advisors LLC increased its stake in shares of Xylem by 2.2% during the first quarter. Perennial Advisors LLC now owns 49,127 shares of the industrial products company's stock valued at $5,869,000 after buying an additional 1,036 shares during the period. Finally, Wedmont Private Capital increased its position in Xylem by 6.1% during the 1st quarter. Wedmont Private Capital now owns 2,348 shares of the industrial products company's stock valued at $256,000 after purchasing an additional 136 shares during the period. Hedge funds and other institutional investors own 87.96% of the company's stock.

About Xylem

(Get Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.